Lonza also makes ingredients for ex-U.S. supplies Rovi CEO: Deal a significant growth opportunity
MADRID, April 12 (Reuters) - Contract drugmaker Rovi
is to make active ingredients for Moderna s
COVID-19 vaccine, extending an existing agreement to bottle the
vaccine using ingredients brought in from Switzerland.
Madrid-based Rovi, whose shares rose 4% on Monday towards a
record high set last month, will build capacity to supply active
agents for up to 100 million vaccine doses annually for Moderna
from its plant in the southern city of Granada via a new
production line.
Another Rovi plant near Madrid has already been bottling, or filling and finishing, Moderna vaccine ingredients being
Schools need mowing help; mowing acreage has nearly doubled in size journalnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalnow.com Daily Mail and Mail on Sunday newspapers.
Message :
Required fields Recently, Aisino signed a contract for the VAT management system project of Dajia Insurance Group to help its digital transformation of its taxation and meet its needs of tax informatization and high-quality development. In this project, Aisino will provide a personalized VAT invoice management solution for its all-risks products to establish a management system of output VAT, input VAT and tax declaration, taking into account the business scenarios and tax informatization construction needs of Dajia Insurance Group. Once the new system is put into operation, the functions of issuing all-invoice-types, automatic collection, checking and certification of input invoice, online statistical analysis of relevant data, and one-key declaration will be realized, which will significantly improve the efficiency of tax-related work and reduce enterprises costs relating to taxation.